RxDoctor Payments Data

Timothy Smith, MD

Family Medicine · Huntsville, TNNPI 1720021660

Payments from drug & device makers

$1,903in general payments, 2019–2025

Across 20 payments — averaging $95.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Novo Nordisk$124
  • AbbVie$105
  • Bayer$17
  • GSK$16
  • Pfizer$15
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$1,53581%
  • Food & beverage$36719%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific5$1,612
Novo Nordisk7$124
AbbVie4$105
Bayer1$17
GSK1$16
Pfizer1$15
Lilly USA, LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,903 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$266,965
Medicare patients
428
Services billed
15,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban187$164,848
TrulicityDulaglutide56$78,521
OzempicSemaglutide74$76,463
JardianceEmpagliflozin40$31,717
JanuviaSitagliptin Phosphate34$30,519
MounjaroTirzepatide19$28,743
LinzessLinaclotide16$21,698
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$14,985
Tresiba Flextouch U-200Insulin Degludec13$12,591
XareltoRivaroxaban12$10,884
MyrbetriqMirabegron17$9,323
BrilintaTicagrelor15$9,015
Omeprazole374$5,978
Potassium Chloride408$5,508
Dexlansoprazole DrDexlansoprazole18$5,436

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$164,848187 claims
Lilly USA, LLCTrulicity, Mounjaro$15$107,26475 claims
Novo NordiskOzempic$124$76,46374 claims
AbbVieLinzess, Synthroid$105$24,66268 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta$16$24,01754 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Huntsville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →